January 28, 2008
Two Worcester Execs To Join Board Of Acton Biotech Co.
By Cory Hopkins
Stephen J. DiPalma, CFO for Worcester-based RXi Pharmaceuticals Corp., and Michael Henry, vice president of business development at Athena Diagnostics Inc. of Worcester, will join the board of directors of Acton-based Neuroptix Corp.
Neuroptix specializes in developing tests for Alzheimer's Disease.
RXi was co-founded by 2006 Nobel Prize winner Craig Mello. Athena Diagnostics is a specialty brand of Waltham-based Thermo Fisher Scientific.
The duo will help Neuroptix move its Alzheimer's diagnostic technology into clinical trials, said Paul Hartung, president and CEO of Neuroptix.
Neuroptix specializes in developing tests for Alzheimer's Disease.
RXi was co-founded by 2006 Nobel Prize winner Craig Mello. Athena Diagnostics is a specialty brand of Waltham-based Thermo Fisher Scientific.
The duo will help Neuroptix move its Alzheimer's diagnostic technology into clinical trials, said Paul Hartung, president and CEO of Neuroptix.
WBJ Web Partners
Most Recent
Most Recent
0 Comments